"10.1371_journal.pone.0143847","plos one","2015-12-02T00:00:00Z","Rikio Suzuki; Shohei Kikuchi; Takeshi Harada; Naoya Mimura; Jiro Minami; Hiroto Ohguchi; Yasuhiro Yoshida; Morihiko Sagawa; Gullu Gorgun; Diana Cirstea; Francesca Cottini; Jana Jakubikova; Yu-Tzu Tai; Dharminder Chauhan; Paul G Richardson; Nikhil Munshi; Kiyoshi Ando; Teruhiro Utsugi; Teru Hideshima; Kenneth C Anderson","Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Tsukuba Research Center, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan; VA Boston Healthcare System, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America","Conceived and designed the experiments: RS SK T. Harada D. Cirstea JJ YTT D. Chauhan KA TU T. Hideshima KCA. Performed the experiments: RS SK T. Harada N. Mimura JM HO YY MS GG FC T. Hideshima. Analyzed the data: RS SK T. Harada D. Chauhan PGR N. Munshi T. Hideshima KCA. Wrote the paper: RS SK T. Harada T. Hideshima KCA.","The authors of this manuscript have the following competing interests: T.U. is an employee at Taiho Pharmaceutical Co., Ltd. Y.-T.T. is a consultant for Onyx. D.C. is a consultant for Oncopeptides AB. P.G.R. is a member of the advisory boards for Celgene, Millennium, Johnson & Johnson, Novartis, and Bristol-Myers Squibb. N.M. is a member of the advisory boards for Millennium, Celgene, and Novartis. T.H. is a consultant for Acetylon Pharmaceuticals. K.C.A. is a member of the advisory boards for Onyx, Celgene, Gilead, and Sanofi-Aventis, and is a scientific founder of Acetylon and Oncopep. J.M. receives research funding from Bristol-Myers Squibb. The other authors declare no conflicts of interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","12","Rikio Suzuki","RS",20,TRUE,3,3,3,3,TRUE,TRUE,TRUE,14,"4;5;6;7;8;9;10;11;12;14;15;16;17;20",TRUE
